2024 Exhibitors & Sponsors

Founded in 1978, Biogen is a leading biotechnology company that pioneers innovative science to deliver new medicines to transform patients’ lives and to create value for shareholders and our communities. We apply deep understanding of human biology and leverage different modalities to advance first-in-class treatments or therapies that deliver superior outcomes. Our approach is to take bold risks, balanced with return on investment to deliver long-term growth.

At Eisai Inc., human health care (hhc) is our mission and is the shared purpose that connects us to those we serve creating a network of powerful relationships that enables us to identify, understand and work to address the needs of people throughout their lives. We boldly push past the boundaries of science and aim to deliver life-changing therapies and health-related solutions that matter to people and society. We bring together science, technology and real-world expertise to pursue a world free from cancer, Alzheimer’s disease and other neurodegenerative diseases.

Everything we do is guided by the simple principle that patients and their families come first, and we have a responsibility to listen to and learn from them.

Eisai Inc. is the U.S. pharmaceutical subsidiary of Tokyo-based Eisai Co., Ltd. The company’s presence in the U.S. includes three discovery centers as well as commercial, clinical development and global demand organizations. To learn more about Eisai, please visit us at www.eisai.com/US and follow us on Twitter and LinkedIn. For more information on our work in neurology, please visit the Eisai U.S. Neurology LinkedIn page.

Physicians' Education Resource® (PER®) is committed to advancing patient care through professional education. Accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), The Council on Optometric Practitioner Education (COPE®) and approved as a nursing continuing education provider by the California Board of Registered Nursing (CBRN), PER® provides high-quality, evidence-based activities featuring leading faculty. PER® plans, develops, implements, and evaluates educational activities using a wide variety of formats targeted to the needs of the healthcare providers we serve. Our CME/CE-certified activities enable health care providers, to remain current and responsive to advances in medical care, from diagnosis through treatment, with the ultimate goal of improving patient outcomes.

ITF Therapeutics, a subsidiary of Italfarmaco Group, was established in January 2024 and received FDA approval on March 21, 2024 for DUVYZAT (givinostat). DUVYZAT, an HDAC inhibitor for treatment of Duchenne’s Muscular Dystrophy, is the first nonsteroidal drug approved to treat patients with all genetic variants of DMD. Please see full Prescribing Information and Medication Guide on duvyzat.com.

Lilly unites caring with discovery to create medicines that make life better for people around the world. We've been pioneering life-changing discoveries for nearly 150 years, and today our medicines help more than 51 million people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges, redefining diabetes care, treating obesity and curtailing its most devastating long-term effects, advancing the fight against Alzheimer's disease, providing solutions to some of the most debilitating immune system disorders, and transforming the most difficult-to-treat cancers into manageable diseases. With each step toward a healthier world, we're motivated by one thing: making life better for millions more people. That includes delivering innovative clinical trials that reflect the diversity of our world and working to ensure our medicines are accessible and affordable. To learn more, visit Lilly.com and Lilly.com/newsroom.

Sarepta Therapeutics is on an urgent mission: engineer precision genetic medicine for rare diseases that devastate lives and cut futures short. We hold leadership positions in Duchenne muscular dystrophy (DMD) and limb-girdle muscular dystrophies (LGMDs), and we currently have more than 40 programs in various stages of development. Our vast pipeline is driven by our multi-platform Precision Genetic Medicine Engine in gene therapy, RNA and gene editing.

The Peter O’Donnell Jr. Brain Institute recognizes that in order to solve the most challenging brain diseases, our work must be multidisciplinary. To achieve this, we integrate and leverage the strengths of multiple independent departments, centers, and divisions at UT Southwestern Medical Center. By bringing together clinical and basic researchers in a comprehensive Institute, we are fostering collaborations and providing resources that set the stage for progress and discovery as we work toward our vision of a future without brain disease

At AdventHealth, Extending the Healing Ministry of Christ is our mission. It calls us to be His hands and feet in helping people feel whole. Our story is one of hope — one that strives to heal and restore the body, mind and spirit.

More than 92,000 skilled and compassionate caregivers in physician practices, hospitals, outpatient clinics, skilled nursing facilities, home health agencies and hospice centers provide individualized, wholistic care.

Our Christian mission, shared vision, common values and focus on whole-person health is our commitment to making communities healthier with a unified system: 51 hospital campuses and hundreds of care sites in diverse markets

AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialization of prescription medicines in Oncology, Rare Diseases and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca operates in over 100 countries. Its innovative medicines are used by millions of patients worldwide. For more information, please visit www.astrazeneca-us.com or Twitter @AstraZeneca US.

Axiva Health Solutions is a home and AIC infusion provider with multiple locations and the ability to ship into 49 states.

The National ALS Registry is a Congressionally mandated program undertaken by ATSDR (the Agency for Toxic Substances and Disease Registry), to better describe the incidence and prevalence of ALS, examine risk factors such as environmental and occupational factors, characterize the demographics of people living with ALS, and support a variety of research into discovering what causes ALS.

At Eisai Inc., human health care (hhc) is our mission and is the shared purpose that connects us to those we serve creating a network of powerful relationships that enables us to identify, understand and work to address the needs of people throughout their lives. We boldly push past the boundaries of science and aim to deliver life-changing therapies and health-related solutions that matter to people and society. We bring together science, technology and real-world expertise to pursue a world free from cancer, Alzheimer’s disease and other neurodegenerative diseases.

Everything we do is guided by the simple principle that patients and their families come first, and we have a responsibility to listen to and learn from them.

Eisai Inc. is the U.S. pharmaceutical subsidiary of Tokyo-based Eisai Co., Ltd. The company’s presence in the U.S. includes three discovery centers as well as commercial, clinical development and global demand organizations. To learn more about Eisai, please visit us at www.eisai.com/US and follow us on Twitter and LinkedIn. For more information on our work in neurology, please visit the Eisai U.S. Neurology LinkedIn page.

GBR Medical delivers innovative solutions that help patients improve their healthcare journey.

Immunovant, Inc. is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases. As a trailblazer in anti-FcRn technology, the Company is developing innovative, targeted therapies to meet the complex and variable needs of people with autoimmune diseases.

Since its inception in 1992, Medeia Inc has been on the forefront in the manufacture and distribution of Neuro Diagnostic and Heart Rate Variability / ANS products. Medeia Inc specializes in the development of state-of-the-art biometrical software and hardware products intended to monitor physiology.

Meds Global has products designed to improve and optimize the performance of medical workers and make patients feel comfortable and improve their care. The company has rich experience in health products and non-invasive equipment.

Neuroelectrics is a Spanish company pioneer in brain stimulation and artificial intelligence technologies and therapies to alleviate neurological diseases.

The company currently offers the best-in-class non-invasive and high-definition electrical brain stimulation technology for personalized neuromodulation. By measuring and modifying brain function, they aim to restore brain health, minimize disabilities, and create a better life for patients.

Founded in 2011 and headquartered in Barcelona and Boston, Neuroelectrics distributes its products in more than 40 countries for basic neuroscience and clinical research in hundreds of universities and academic medical centers. Their vision is to create a powerful neurotechnology platform upon which verticals can be developed to improve the lives of as many people as possible. Clinical applications are already being developed to diagnose and treat brain diseases as well as improve brain health (e.g., in epilepsy, neuropathic pain, or mood disorders) and cognitive function (e.g., memory in dementia or executive function in children with ADHD).

Omniscient (o8t™) is the world leader in using AI to decode the human brain – a field known as connectomics. We are an artificial intelligence research hub which creates advanced technologies to conquer the problems and enhance the potential of the human brain to the benefit of all humankind. Our mission is to improve the lives of billions through connectomics. Already used by neurosurgeons to visualize the brain’s pathways prior to a procedure, Omniscient’s connectomics AI platform – Quicktome™ – is poised to revolutionize brain health and help conquer conditions such as Alzheimer’s disease and depression through truly precision brain medicine. To learn more, visit o8t.com.

RosmanSearch, the leader in specialized physician recruitment, merges data-driven insights and a tenured team of specialists to strategically place experts in neurosurgery, neurology, urology, gastroenterology, and hospitalist medicine, ensuring each match — whether permanent, executive, or locum tenens — elevates healthcare standards with unmatched precision.

Founded in 2000, SomaLogic is a global leader in proteomics. Powered by an industry-leading technology platform and one of the largest clinical proteomic databases in the world, we aim to revolutionize precision medicine to help address unmet medical needs. SomaLogic offers the most powerful proteomics solution, enabling 11,000 protein measurements (10,000 unique human proteins). Their proprietary SomaScan® Assay measures proteins with high specificity, low variance and high reproducibility, which enables the possibility of faster, more precise drug discovery. Recently, SomaLogic has joined Standard Biotools. Together, we work with leading academic, government, pharmaceutical, biotechnology, plant and animal research, and clinical laboratories worldwide, focusing on the most pressing needs in translational and clinical research, including oncology, neurology, immunology, and immunotherapy.

Sutter Health is a not-for-profit health system that delivers top-rated personalized care in more than 100 Northern California communities. It was recently ranked among the Top 15 Health Systems in the nation by Truven Health Analytics. As a not-for-profit, Sutter Health invests its earnings back into the communities it serves.

Tampa General Hospital, a 981-bed, not-for-profit, academic health system, is one of the largest hospitals in America and delivers world-class care as the region’s only center for Level l trauma and comprehensive burn care. Tampa General Hospital is the highest-ranked hospital in the market in U.S. News & World Report's 2024-2025 Best Hospitals, with two medical specialties ranking among the top 20 in the nation and eight medical specialties ranking among the top 50 best hospital programs in the United States. TGH is the primary teaching hospital for the USF Health Morsani College of Medicine and partners with them to pioneer breakthrough treatments, conduct game-changing clinical research and train the next generation of healthcare professionals.

The Lambert-Eaton LEMS Family Association is a 501c3 nonprofit. Our mission, to strengthen Awareness, Research, and Family for the Lambert-Eaton Myasthenia Syndrome (LEMS) community. We increase awareness of LEMS in the medical and research communities, have a patient Registry, and build a greater sense of family in the LEMS community.

thinkCADASIL is a group of patients and patient advocates dedicated to providing CADASIL education to the community at large. We provide CADASIL information through social media PSAs, interviews and in person events. We also raise funds for research through various campaigns during the year. You can find us at thinkCADASIL.org.

UCB is a global biopharmaceutical company with headquarters in Belgium and across nearly 40 countries worldwide, focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system.

UHealth – University of Miami Health System delivers leading-edge patient care by the region’s best doctors, powered by the groundbreaking research of the University of Miami Leonard M. Miller School of Medicine. As South Florida’s only university-based medical system, UHealth is a vital component of the community that is leading the next generation of health care.

UHealth combines exceptional patient care, breakthrough research, and novel education to create an innovative approach to health care. Within the UHealth system, patients can participate in clinical trials and benefit from the latest discoveries that are fast-tracked from the laboratory to the bedside.

UHealth is made up of more than 1,800 providers and scientists who are highly trained specialists focused on providing state-of-the-art medical care. From diagnosis to treatment and follow-up, physicians work in teams to deliver care that is tailored to each patient.

Patients from around the world turn to UHealth in their search for expert care from our top ranked physicians. UHealth is home to the number one eye hospital in the United States, Bascom Palmer Eye Institute, the only NCI-designated cancer center in South Florida, Sylvester Comprehensive Cancer Center, a pioneering minimally invasive cardiac surgery program, and offers expertise in more than 100 medical specialties. UHealth’s comprehensive network also includes nearly 40 outpatient sites in Miami-Dade, Broward, Palm Beach, and Collier counties, including The Lennar Foundation Medical Center.

UHealth is ranked among the best hospitals in Florida by U.S. News & World Report Best Hospitals 2024-25 — recognized in 15 areas of care with high-performing ratings in two adult specialties and 11 procedures and conditions and a national ranking in two adult specialties:

Bascom Palmer Eye Institute—No. 1 in ophthalmology for the 23rd time.

Ranked among the best in the nation for neurology and neurosurgery for the fourth consecutive year.

Hospitals that earned a High Performing rating were significantly better than the national average, as measured by factors such as patient outcomes, complication rates, patient experience, and level of nursing care.

Headquartered in Pittsburgh, Pennsylvania, UPMC is a world-renowned health care provider and insurer. We're a global leader in groundbreaking research, treatments, and clinical care. UPMC has more than 40 hospitals and 800 doctors' offices and outpatient centers:

Across Pennsylvania.
In Maryland and New York.
In Ireland, Italy, and around the world.

At Eisai Inc., human health care (hhc) is our mission and is the shared purpose that connects us to those we serve creating a network of powerful relationships that enables us to identify, understand and work to address the needs of people throughout their lives. We boldly push past the boundaries of science and aim to deliver life-changing therapies and health-related solutions that matter to people and society. We bring together science, technology and real-world expertise to pursue a world free from cancer, Alzheimer’s disease and other neurodegenerative diseases.

Everything we do is guided by the simple principle that patients and their families come first, and we have a responsibility to listen to and learn from them.

Eisai Inc. is the U.S. pharmaceutical subsidiary of Tokyo-based Eisai Co., Ltd. The company’s presence in the U.S. includes three discovery centers as well as commercial, clinical development and global demand organizations. To learn more about Eisai, please visit us at www.eisai.com/US and follow us on Twitter and LinkedIn. For more information on our work in neurology, please visit the Eisai U.S. Neurology LinkedIn page.